Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_assertion type Assertion NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_head.
- NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_assertion description "[Collectively, our data indicate that ERBB2-mediated breast cancer progression requires ?-catenin signaling and can be therapeutically targeted by selective ?-catenin/CBP inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_provenance.
- NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_assertion evidence source_evidence_literature NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_provenance.
- NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_assertion SIO_000772 23720052 NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_provenance.
- NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_assertion wasDerivedFrom befree-20150227 NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_provenance.
- NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_assertion wasGeneratedBy ECO_0000203 NP372170.RAgbdvB_nneYrkrx_edqsj8mm43prhURCdD8A73kPj8RM130_provenance.